1. Insulin Therapy and Colorectal Adenoma Risk Among Patients with Type 2 Diabetes Mellitus: A Case-Control Study in Korea
- Author
-
Yong Woo Chung, Kyo-Sang Yoo, Dong Soo Han, Chang Soo Eun, Choong Kee Park, and Kwang Hyuk Park
- Subjects
Adenoma ,Male ,Risk ,medicine.medical_specialty ,endocrine system diseases ,Colorectal cancer ,medicine.medical_treatment ,Colorectal adenoma ,Type 2 diabetes ,Internal medicine ,Diabetes mellitus ,Humans ,Insulin ,Medicine ,Risk factor ,Aged ,Proportional Hazards Models ,Retrospective Studies ,Chi-Square Distribution ,Korea ,business.industry ,Gastroenterology ,Case-control study ,Type 2 Diabetes Mellitus ,Colonoscopy ,General Medicine ,medicine.disease ,Surgery ,Logistic Models ,Diabetes Mellitus, Type 2 ,Case-Control Studies ,Female ,Colorectal Neoplasms ,business - Abstract
Patients with Type 2 diabetes mellitus may be at increased colorectal adenoma and cancer risk. Moreover, chronic insulin therapy may increase the risk of colorectal cancer among patients with Type 2 diabetes mellitus. We investigated to determine whether insulin therapy might increase the risk of colorectal adenoma among clinically confirmed patients with Type 2 diabetes mellitus. We conducted a retrospective study among patients with Type 2 diabetes mellitus who underwent total colonoscopy between January 2003 and July 2006 at Hallym University Sacred Heart Hospital. Among them (n = 325), patients with histologically confirmed colorectal adenomas (n = 100) and the same number of controls matched by age and sex were selected and analyzed. Adenoma cases showed significantly higher rate of chronic insulin therapy (more than 1 year) than controls (P = 0.018). In multivariate regression analysis, patients who received chronic insulin therapy had three times the risk of colorectal adenoma compared with patients who received no insulin (odds ratio, 3; 95 percent confidence interval, 1.1–8.9; P = 0.04). Chronic insulin therapy was associated with increased colorectal adenoma risk among Type 2 diabetes mellitus patients. This result may provide a need for more intensive colorectal cancer screening program in patients with Type 2 diabetes mellitus, especially those who receive chronic insulin therapy.
- Published
- 2008